About Civica:



Over the past two decades, shortages of generic, injectable medications critical to the lifesaving work of hospitals in the United States have become commonplace and have reached an all time high. Over 300 essential medications are reported to be in shortage, according to industry and FDA reports. "Race to the bottom" pricing of mostly sterile injectable medications, manufacturing challenges and predatory pricing are both the causes and results.


Who suffers most? Patients.



Civica is a 501(c)(4) social welfare organization established in 2018 by health systems (CommonSpirit Health, HCA Healthcare, Intermountain Healthcare, Mayo Clinic, Providence St. Joseph Health, SSM Health, and Trinity Health) and philanthropies (Gary and Mary West Foundation, Laura and John Arnold Foundation, and Peterson Center on Healthcare) to reduce chronic generic drug shortages and related high prices in the United States. An experienced team of health care and pharmaceutical industry leaders leads the organization.


Today, more than 55 health systems have joined Civica. They represent over 1,500 hospitals and over 30 percent of all U.S. hospital beds. Civica has also supplied the U.S. Department of Veteran's Affairs, the U.S. Department of Defense, and the U.S. Strategic National Stockpile of essential medicines. Since established, the #1 Policy for the Civica team has been "Do What Is in the Best Interest of Patients."


Civica has expanded its mission beyond the hospital setting to include lowering the cost of medications at the pharmacy counter. It has launched a sister organization, CivicaScript, to enter the retail pharmacy market partnering with Blue Cross Blue Shield entities and others with the goal of reducing select high cost generic drugs where market forces are not working to control drug costs.


More recently, Civica announced plans to develop, manufacture and deliver affordable biosimilar insulin, The consistent availability of affordable insulin will benefit people who ration their care or who have been forced to choose between this life-sustaining medicine and living expenses. Those who are uninsured or underinsured often pay the most out of pocket for their medications.


Long- and short-acting insulins will be produced and available in both vials and pre-filled pens - at no more than $30 per vial and no more than $55 for a pack of five pens.


Learn more about Civica's plans and progress at www.civicarx.org



Job Description:


The Supply Chain Manager, Insulin and External Partners will be responsible for implementing and managing Civica's external partners and Insulin as it pertains to manufacturing and distribution at the Civica Petersburg, VA site. The responsibilities include forecasting, procurement of materials and components, supply planning, production planning, capacity planning, externals partners relationship management, and distribution strategy and execution.



Essential Duties and Responsibilities:


The essential functions include, but are not limited to the following:

• Manages relationships with external partners by acting as the primary point of contact for their activities including forecasting, material availability, prioritization, supply timing, and business reviews.


• Executes Insulin supply chain activities including forecasting, procurement, logistics, production planning, capacity planning, and supply planning.


• Manages site Insulin forecasting responsibilities between business demand and material requirements planning (MRP).


• Creates and maintains purchase orders and production orders in company enterprise resource planning (ERP) system.


• Develops and delivers the Sales and Operations Planning (S&OP) process for Insulin and external partners.


• Manages logistics of components and product to and from the manufacturing facility. This includes samples to contract laboratories as required.


• Manages the clinical supply chain for insulin production, testing, and supply.


• Responsible for shipping validation of Insulin drug substance and drug product.


• Manages flow of product from requirements through distribution, ensuring on-time and in-full delivery of product.


• Develops and maintains written Insulin specific procedures as it pertains to procurement, production planning, and logistics.


• Completes thorough root cause investigations and corrective actions for any deviations in a timely manner.


• Supports the warehouse and supply chain team with site logistics requirements.


• Supports site operations during regulatory/compliance audits.

• Bachelor's degree in related area and 5 years in Supply Chain Management, Project Management and/or Procurement in a cGMP environment. Parenteral pharmaceutical experience preferred.


• Advanced computer applications skills (Excel, Word, Visio, ERPs, and PP).


• Experience in the use an ERP/ MRP is required.


• Excellent written and oral communication and presentation skills with the ability to speak and communicate effectively with both senior management and front-line staff personnel.


• Project Management, Operational Excellence, and/or Lean/Six Sigma experience preferred.